Social but safe? Quality and safety of diabetes-related online social networks.
OBJECTIVE
To foster informed decision-making about health social networking (SN) by patients and clinicians, the authors evaluated the quality/safety of SN sites' policies and practices.


METHODS
Multisite structured observation of diabetes-focused SN sites. Measurements 28 indicators of quality and safety covering: (1) alignment of content with diabetes science and clinical practice recommendations; (2) safety practices for auditing content, supporting transparency and moderation; (3) accessibility of privacy policies and the communication and control of privacy risks; and (4) centralized sharing of member data and member control over sharing.


RESULTS
Quality was variable across n=10 sites: 50% were aligned with diabetes science/clinical practice recommendations with gaps in medical disclaimer use (30% have) and specification of relevant glycosylated hemoglobin levels (0% have). Safety was mixed with gaps in external review approaches (20% used audits and association links) and internal review approaches (70% use moderation). Internal safety review offers limited protection: misinformation about a diabetes 'cure' was found on four moderated sites. Of nine sites with advertising, transparency was missing on five; ads for unfounded 'cures' were present on three. Technological safety was poor with almost no use of procedures for secure data storage and transmission; only three sites support member controls over personal information. Privacy policies' poor readability impedes risk communication. Only three sites (30%) demonstrated better practice. Limitations English-language diabetes sites only.


CONCLUSIONS
The quality/safety of diabetes SN is variable. Observed better practice suggests improvement is feasible. Mechanisms for improvement are recommended that engage key stakeholders to balance autonomy, community ownership, conditions for innovation, and consumer protection.
Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Children's Hospital Boston, Boston, Massachusetts, USA. elissa.weitzman@childrens.harvard.edu
Elissa R
ER
Weitzman
Emily
E
Cole
Liljana
L
Kaci
Kenneth D
KD
Mandl
D016494:Computer Security; D003219:Confidentiality; D054626:Consumer Health Information; D003920:Diabetes Mellitus / Q000628:therapy*; D006801:Humans; D033181:Information Dissemination; D020407:Internet; D011787:Quality of Health Care; D012449:Safety; D012944:Social Support; D014481:United States
BMJ. 2001 Oct 20;323(7318):908-11
11668137
J Med Internet Res. 2009 Nov 27;11(4):e48
19945947
PLoS Med. 2006 Apr;3(4):e189
16597179
N Engl J Med. 2005 Jan 27;352(4):325-8
15673797
J Gen Intern Med. 2011 Mar;26(3):287-92
20945113
J Am Med Inform Assoc. 2010 Jul-Aug;17(4):373-4
20595302
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
19896746
Yearb Med Inform. 2010;:72-4
20938575
Stud Health Technol Inform. 2007;129(Pt 1):162-6
17911699
Med Care. 2004 Dec;42(12):1176-85
15550797
Med Care. 2005 Nov;43(11):1123-9
16224306
Am J Community Psychol. 2002 Oct;30(5):637-54
12188054
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
20042772